ArticleCureus2026
Severe Parathyroid Hormone (PTH)-Independent Hypercalcemia Revealing Precursor B-cell Acute Lymphoblastic Leukemia in a Two-Year-Old Male: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypercalcemia is an uncommon metabolic disorder in children and a rare complication of pediatric malignancies. Acute lymphoblastic leukemia (ALL) presenting with severe hypercalcemia and osteolytic bone lesions is rare in pediatric patients. We report the case of a previously healthy two-year-old male who presented with a one-month history of progressive lower limb weakness, fatigue, and altered responsiveness. Guillain-Barré syndrome was initially suspected but became less likely following normal electromyography (EMG) and spinal MRI findings. Initial investigations revealed severe hypercalcemia (212 mg/L; 5.3 mmol/L), hypophosphatemia, hyperuricemia, elevated lactate dehydrogenase (LDH) levels, and mildly impaired renal function. A shortened QT interval on ECG prompted pediatric ICU (PICU) admission, where the patient received hyperhydration and bisphosphonates, resulting in partial biochemical improvement. Endocrine evaluation showed suppressed parathyroid hormone (PTH) (4 pg/mL), normal 25-OH vitamin D (23 ng/mL), and normal thyroid function tests, supporting a PTH-independent etiology of hypercalcemia. Persistent hypercalcemia combined with microcytic anemia, elevated uric acid, and LDH levels raised suspicion of an underlying malignancy. Skeletal radiographs demonstrated multiple bilateral osteolytic lesions involving the femurs, tibias, and fibulas. Bone marrow aspiration revealed 27% blasts, and flow cytometry demonstrated a CD34-positive and CD45-dim blast population consistent with precursor B-cell ALL. Serum calcium normalized progressively before chemotherapy initiation after initial aggressive hyperhydration followed by repeated zoledronic acid administration, and the patient was subsequently transferred to the oncology department for treatment according to the ALL IC-BFM 2009 protocol. Clinical and neurological improvement followed progressively. This report highlights the diagnostic challenge of malignant hypercalcemia in children, particularly in the absence of circulating blasts or organomegaly. Severe PTH-independent hypercalcemia associated with osteolytic lesions should raise suspicion for ALL, even in very young children. Skeletal radiography provided the pivotal diagnostic clue after a one-month delay in diagnosis, ultimately leading to bone marrow evaluation and diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.